BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wang Y, Wei L, Jiang D, Cong X, Fei R, Xiao J, Wang Y. In vitro resistance to interferon of hepatitis B virus with precore mutation. World J Gastroenterol 2005; 11(5): 649-655 [PMID: 15655815 DOI: 10.3748/wjg.v11.i5.649]
URL: https://www.wjgnet.com/1007-9327/full/v11/i5/649.htm
Number Citing Articles
1
Rong-Juan Pei, Xin-Wen Chen, Meng-Ji Lu. Control of hepatitis B virus replication by interferons and Toll-like receptor signaling pathwaysWorld Journal of Gastroenterology 2014; 20(33): 11618-11629 doi: 10.3748/wjg.v20.i33.11618
2
X. B. Pan, L. Wei, H. S. Chen, F. Liu, Y. Gao. Liver-derived cell lines QSG-7701 and HepG2 support different HBV replication patternsArchives of Virology 2007; 152(6): 1159 doi: 10.1007/s00705-006-0927-4
3
L. J. Liu, J. H. Wang, S. C. Du, J. H. Tian, R. F. Yang, L. Wei. rtE218G, a novel hepatitis B virus mutation with resistance to adefovir dipivoxil in patients with chronic hepatitis BJournal of Viral Hepatitis 2010; 17(s1): 66 doi: 10.1111/j.1365-2893.2010.01273.x
4
M. A. Aslam, F. R. Awan, I. Tauseef, S. Ali, N. Ahmad, N. A. Malik, M. N. Riaz, J. A. Qureshi. Identification of hepatitis B virus core mutants by PCR-RFLP in chronic hepatitis B patients from Punjab, PakistanArchives of Virology 2008; 153(1): 163 doi: 10.1007/s00705-007-1093-z
5
Jianghua Wang, Haiying Zhang, Yingjun Zhang, Dong Jiang, Jing Li, Siegfried Goldmann, Qingyun Ren, Ran Fei, Xueyan Wang, Lai Wei. Influences on viral replication and sensitivity to GLS4, a HAP compound, of naturally occurring T109/V124 mutations in hepatitis B virus core proteinJournal of Medical Virology 2017; 89(10): 1804 doi: 10.1002/jmv.24830
6
Max Q. Arens, Ella M. Swierkosz. Clinical Virology Manual2009; : 134 doi: 10.1128/9781555815974.ch12
7
Mengxin Lin, Ruyi Guo, Cuiping Ma, Dawu Zeng, Zhijun Su. Manganese Breaks the Immune Tolerance of HBs-AgOpen Forum Infectious Diseases 2021; 8(2) doi: 10.1093/ofid/ofab028
8
Hui Ma, Xing-Liang Zhao, Xue-Yan Wang, Xing-Wang Xie, Jin-Chao Han, Wen-Li Guan, Qin Wang, Lin Zhu, Xiao-Ben Pan, Lai Wei, Wenyu Lin. 2’,3’-Cyclic Nucleotide 3’-Phosphodiesterases Inhibit Hepatitis B Virus ReplicationPLoS ONE 2013; 8(11): e80769 doi: 10.1371/journal.pone.0080769
9
Max Q. Arens, Ella M. Swierkosz. Manual of Clinical Microbiology2011; : 1729 doi: 10.1128/9781555816728.ch110
10
Quan Zhang, Yan Wang, Lai Wei, Dong Jiang, Jiang Hua Wang, Hui Ying Rao, Ling Zhu, Hongsong Chen, Ran Fei, Xu Cong. Role of ISGF3 in modulating the anti‐hepatitis B virus activity of interferon‐alpha in vitroJournal of Gastroenterology and Hepatology 2008; 23(11): 1747 doi: 10.1111/j.1440-1746.2007.04985.x
11
Huguang Chen, Shuya Luo, Weili Lu, Zhi Chen, Jiamin Chen, Shu Zheng, Jiekai Yu. Serum protein expression patterns in detecting a new viral protein in HBeAg‐negative chronic hepatitis BJournal of Viral Hepatitis 2019; 26(S1): 90 doi: 10.1111/jvh.13166
12
Yanan Guo, He Lu, Lei Xu, Nur Fazleen Binti Idris, Yimin Li, Jieli Hu, Ailong Huang, Zeng TU. The response of hepatitis B virus genotype to interferon is associated with a mutation in the interferon-stimulated response elementMedicine 2019; 98(51): e18442 doi: 10.1097/MD.0000000000018442
13
Lawrence Ehis Okoror, Ayodele Oluwaseun Ajayi, Oluwaseun Benjamin Ijalana. Elevated serum β2-microglobulin in individuals coinfected with hepatitis B and hepatitis D virus in a rural settings in Southwest NigeriaBMC Research Notes 2017; 10(1) doi: 10.1186/s13104-017-3015-9
14
Jia-Jie Lu, En-Qiang Chen, Jia-Hong Yang, Tao-You Zhou, Li Liu, Hong Tang. A mutation in the interferon regulatory element of HBV may influence the response of interferon treatment in chronic hepatitis B patientsVirology Journal 2012; 9(1) doi: 10.1186/1743-422X-9-10
15
Xue-Yan Wang, Zhen-Man Wei, Guo-Yi Wu, Jiang-Hua Wang, Ying-Jun Zhang, Jing Li, Heng-Hui Zhang, Xing-Wang Xie, Xian Wang, Zhao-He Wang, Lai Wei, Yu Wang, Hong-Song Chen. In vitro inhibition of HBV replication by a novel compound, GLS4, and its efficacy against adefovir-dipivoxil-resistant HBV mutationsAntiviral Therapy 2012; 17(5): 793 doi: 10.3851/IMP2152
16
Stephen Locarnini, William S. Mason. Cellular and virological mechanisms of HBV drug resistanceJournal of Hepatology 2006; 44(2): 422 doi: 10.1016/j.jhep.2005.11.036